Bayesian designs of phase II oncology trials to select maximum effective dose assuming monotonic dose-response relationship
Crossref DOI link: https://doi.org/10.1186/1471-2288-14-95
Published Online: 2014-07-29
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guo, Beibei
Li, Yisheng
License valid from 2014-07-29
Article History
Received: 10 February 2014
Accepted: 15 July 2014
First Online: 29 July 2014